Bulian Deng

Novel CRBN-Recruiting Proteolysis-Targeting Chimeras as Degraders of Stimulator of Interferon Genes with In Vivo Anti-Inflammatory Efficacy

Jin Liu, L. Yuan, Yong Ruan et al. · Journal of Medicinal Chemistry · 2022 · 95 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Discovery of pomalidomide-based PROTACs for selective degradation of histone deacetylase 8

Zhiqiang Sun, Bulian Deng, Zichao Yang et al. · European Journal of Medicinal Chemistry · 2022 · 40 citations

Life Sciences, Molecular Biology, Pharmacology +15

Discovery of Thieno[2,3-d]pyrimidine-based KRAS G12D inhibitors as potential anticancer agents via combinatorial virtual screening

Ling Li, Jin Liu, Zichao Yang et al. · European Journal of Medicinal Chemistry · 2022 · 29 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +13

Design, Synthesis, and Bioevaluation of Novel Enzyme-Triggerable Cell Penetrating Peptide-Based Dendrimers for Targeted Delivery of Camptothecin and Cancer Therapy

Ruiyao Mai, Bulian Deng, Huiting Zhao et al. · Journal of Medicinal Chemistry · 2022 · 21 citations

Pharmacy, Medicinal Chemistry, Oncology +17

RETRACTED ARTICLE: Discovery of novel benzohydroxamate-based histone deacetylase 6 (HDAC6) inhibitors with the ability to potentiate anti-PD-L1 immunotherapy in melanoma

Xiaopeng Peng, Ziwen Yu, Goverdhan Surineni et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2023 · 19 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14